Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Plant-Derived Pharmaceuticals by Molecular Farming"
Deadline for manuscript submissions: closed (31 March 2011).
Tel. +82-42-520-5617; Fax: +82-70-4362-6308
Interests: plant-derived biomedicines; plant-made pharmaceuticals; molecular farming; recombinant proteins; plant metabolic engineering; hypoglycaemic; hypolipidemic; antioxidants; antiviral; bacterial ghost vaccine; inactivated vaccine; subunit vaccine
Special Issues and Collections in MDPI journals
Special Issue in International Journal of Molecular Sciences: Plant-Derived Pharmaceuticals by Molecular Farming 2012
Special Issue in International Journal of Molecular Sciences: Pharmaceuticals and Nutraceuticals by Molecular Farming
Special Issue in International Journal of Molecular Sciences: Plant-Derived Pharmaceuticals by Molecular Farming 2016
Special Issue in International Journal of Molecular Sciences: Advances in Cheap Vaccines for Public Goods
Special Issue in International Journal of Molecular Sciences: New Advances in Human Vaccine
This special issue is aimed at both the basic and applied sciences of Plant Molecular Farming (PMF). PMF is the growing and harvesting of genetically engineered crops of transgenic plants, to produce biopharmaceuticals or industrial compounds instead of food, feed, or fibre. The possibilities cover from the manufacture of medical products, such as pharmaceuticals (drugs) and vaccines, to the products of industrial purpose like biodegradable plastics. The advantages of PMF in terms of production scale and economy, product safety, ease of storage and distribution are superior than any current commercial system. Despite the promising benefits, the commercialization of plant-derived pharmaceutical products is lagging by the uncertainty, particularly with regard to the adaptation of good manufacturing practice regulations to field-grown plants. Although it is not yet routinely commercialized, interest and investment in PMF are extending rapidly. PMF will be progressed for the core commercial development in biotechnology. Licensing of full scale production is forthcoming, although cultivated area in field will be very limited and highly regulated, or the initial stage of cultivation may begin in controlled greenhouses. The objective of this special issue is to provide high quality research results on novel gene expression in plants and its industrial or clinical application. I wish to thank all the authors for their contribution to this special issue.
Prof. Dr. Chang Won Choi
- edible vaccines
- antibodies for diagnostic, preventative, and therapeutic applications
- bioplastics made from simple, biodegradable molecules produced in plants
- an enzyme used in the treatment of human and animals
- enzymes for use in food processing
- proteins for industrial purpose